Logo image of INV

INNVENTURE INC (INV) Stock Fundamental Analysis

NASDAQ:INV - Nasdaq - US45784M1080 - Common Stock - Currency: USD

3.96  -0.06 (-1.49%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to INV. INV was compared to 231 industry peers in the Capital Markets industry. INV has a bad profitability rating. Also its financial health evaluation is rather negative. INV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

INV had negative earnings in the past year.
In the past year INV has reported a negative cash flow from operations.
INV Yearly Net Income VS EBIT VS OCF VS FCFINV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M

1.2 Ratios

INV has a worse Return On Assets (-5.67%) than 82.25% of its industry peers.
Looking at the Return On Equity, with a value of -6.67%, INV is doing worse than 79.65% of the companies in the same industry.
Industry RankSector Rank
ROA -5.67%
ROE -6.67%
ROIC N/A
ROA(3y)4.03%
ROA(5y)N/A
ROE(3y)4.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
INV Yearly ROA, ROE, ROICINV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 -2 4 -4

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for INV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INV Yearly Profit, Operating, Gross MarginsINV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

3

2. Health

2.1 Basic Checks

INV has less shares outstanding than it did 1 year ago.
The debt/assets ratio for INV is higher compared to a year ago.
INV Yearly Shares OutstandingINV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
INV Yearly Total Debt VS Total AssetsINV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

INV has an Altman-Z score of 6.91. This indicates that INV is financially healthy and has little risk of bankruptcy at the moment.
INV has a Altman-Z score of 6.91. This is amongst the best in the industry. INV outperforms 91.77% of its industry peers.
INV has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of INV (0.04) is better than 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 6.91
ROIC/WACCN/A
WACCN/A
INV Yearly LT Debt VS Equity VS FCFINV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

INV has a Current Ratio of 0.05. This is a bad value and indicates that INV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of INV (0.05) is worse than 92.64% of its industry peers.
INV has a Quick Ratio of 0.05. This is a bad value and indicates that INV is not financially healthy enough and could expect problems in meeting its short term obligations.
INV has a worse Quick ratio (0.05) than 92.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
INV Yearly Current Assets VS Current LiabilitesINV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

0

3. Growth

3.1 Past

The earnings per share for INV have decreased strongly by -229.59% in the last year.
EPS 1Y (TTM)-229.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-342.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, INV will show a very negative growth in Earnings Per Share. The EPS will decrease by -68.97% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-991.83%
EPS Next 2Y-132.78%
EPS Next 3Y-68.97%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
INV Yearly Revenue VS EstimatesINV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 10M 20M 30M 40M 50M
INV Yearly EPS VS EstimatesINV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

INV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year INV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INV Price Earnings VS Forward Price EarningsINV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INV Per share dataINV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

INV's earnings are expected to decrease with -68.97% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-132.78%
EPS Next 3Y-68.97%

0

5. Dividend

5.1 Amount

No dividends for INV!.
Industry RankSector Rank
Dividend Yield N/A

INNVENTURE INC

NASDAQ:INV (5/6/2025, 4:30:02 PM)

3.96

-0.06 (-1.49%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-11 2025-04-11/bmo
Earnings (Next)N/A N/A
Inst Owners5.62%
Inst Owner Change2.97%
Ins Owners26.35%
Ins Owner Change12.51%
Market Cap186.56M
Analysts80
Price Target14.28 (260.61%)
Short Float %1.89%
Short Ratio6.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.15
P/tB 2.15
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS1.84
TBVpS1.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.67%
ROE -6.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.03%
ROA(5y)N/A
ROE(3y)4.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 6.91
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-229.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-342.43%
EPS Next Y-991.83%
EPS Next 2Y-132.78%
EPS Next 3Y-68.97%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-456.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.25%
OCF growth 3YN/A
OCF growth 5YN/A